Hypothetically, harmonizing the U.S. definition of a cosmetic with that in the European Union could result in fewer FDA warning letters and potentially benefit consumers, but increased leeway for product claims likely would come at a cost to small businesses.
Recent warnings issued to cosmetics manufacturers in the states largely have centered on benefit claims that define recipients’ products as drugs under the Federal Food, Drug and Cosmetic Act, targeting...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?